作者
Jeanne Tie,Joshua D. Cohen,Kamel Lahouel,Serigne Lo,Yuxuan Wang,Suzanne Kosmider,Rachel Wong,Jeremy Shapiro,Margaret Lee,Sam Harris,Adnan Khattak,Matthew Burge,Marion Harris,James Lynam,Louise Nott,Fiona Day,Theresa Hayes,Sue‐Anne McLachlan,Belinda Lee,Janine Ptak,Natalie Silliman,Lisa Dobbyn,Maria Popoli,Ralph H. Hruban,Anne Marie Lennon,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Cristian Tomasetti,Peter Gibbs
摘要
The role of adjuvant chemotherapy in stage II colon cancer continues to be debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor recurrence-free survival, whereas its absence predicts a low risk of recurrence. The benefit of adjuvant chemotherapy for ctDNA-positive patients is not well understood.